FR 139317

FR 139317 features a peptide-based architecture used to investigate ligand-receptor contact patterns. Aromatic and charged residues support complex binding interactions. Researchers examine its conformational equilibrium to interpret structure-activity relationships. Uses include receptor mapping, motif modeling, and peptide optimization.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
FR 139317(CAS 142375-60-8)

CAT No: R2339

CAS No:142375-60-8

Synonyms/Alias:FR 139317;142375-60-8;FR139317;2-((1-(Hexahydro-1H-azepinyl)carbonyl)amino-4-methylpentanoyl)-3-(-(1-methyl-1H-indolyl)propionyl)amino-3-(2-pyridyl)propionic acid;D-Alanine, N-((hexahydro-1H-azepin-1-yl)carbonyl)-L-leucyl-1-methyl-D-tryptophyl-3-(2-pyridinyl)-;CHEMBL352396;(2R)-2-[[(2R)-2-[[(2S)-2-(azepane-1-carbonylamino)-4-methylpentanoyl]amino]-3-(1-methylindol-3-yl)propanoyl]amino]-3-pyridin-2-ylpropanoic acid;D-Alanine, N-(N-(N-((hexahydro-1H-azepin-1-yl)carbonyl)-L-leucyl)-1-methyl-D-tryptophyl)-3-(2-pyridinyl)-;(2R)-2-(((2R)-2-(((2S)-2-(azepane-1-carbonylamino)-4-methylpentanoyl)amino)-3-(1-methylindol-3-yl)propanoyl)amino)-3-pyridin-2-ylpropanoic acid;PD 147953;Tocris-1210;GTPL998;SCHEMBL2124350;DTXSID30931419;HMS3412O03;HMS3676O03;SFA37560;BDBM50286804;AKOS024456467;NCGC00025042-01;NCGC00025042-02;AS-85708;HY-102092;G78199;SR-01000597371;SR-01000597371-1;BRD-K19318328-001-01-3;Q27077729;(2R)-2-{[(2R)-2-({(2S)-2-[(1-azepanylcarbonyl)amino]-4-methylpentanoyl}amino)-3-(1-methyl-1H-indol-3-yl)propanoyl]amino}-3-(2-pyridinyl)propanoic acid;(R)-2-((R)-2-((S)-2-(azepane-1-carboxamido)-4-methylpentanamido)-3-(1-methyl-1H-indol-3-yl)propanamido)-3-(pyridin-2-yl)propanoic acid;(R)-2-[(R)-2-{(S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoylamino}-3-(1-methyl-1H-indol-3-yl)-propionylamino]-3-pyridin-2-yl-propionic acid;D-Alanine,N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-1-methyl-D-tryptophyl-3-(2-pyridinyl)-;N-{2-[(2-{[(Azepan-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(1-methyl-1H-indol-3-yl)propylidene}-3-pyridin-2-ylalanine;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C33H44N6O5
M.W/Mr.
604.7
Sequence
One Letter Code:LXX
Three Letter Code:azepane-1-carbonyl-Leu-D-Trp(Me)-D-2Pal-OH
InChI
InChI=1S/C33H44N6O5/c1-22(2)18-26(37-33(44)39-16-10-4-5-11-17-39)30(40)35-27(19-23-21-38(3)29-14-7-6-13-25(23)29)31(41)36-28(32(42)43)20-24-12-8-9-15-34-24/h6-9,12-15,21-22,26-28H,4-5,10-11,16-20H2,1-3H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43)/t26-,27+,28+/m0/s1
InChI Key
LIOKMIQQPDDTNO-UPRLRBBYSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceCustom Conjugation ServicePeptide CDMOPeptide Modification ServicesEpitope Mapping ServicesPeptide Analysis ServicesPeptide Synthesis ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers